BTIS
WST icon

BB&T Investment Services’s West Pharmaceutical WST Stock Holding History

BB&T Investment Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$12K Sell
115
-4,209
-97% -$413K ﹤0.01% 932
2017
Q3 		$417K Buy
+4,324
New +$391K 0.08% 202

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

BB&T Investment Services's WST Position: Q4 2017 in Review

BB&T Investment Services reduced its West Pharmaceutical (WST) stake by 97% in Q4 2017, selling an estimated $413K and leaving 115 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #932.

BB&T Investment Services first reported a position in WST in Q3 2017 and has held it in 2 quarters since. The position peaked at $417K in Q3 2017. 338 funds tracked by Wall St. Rank hold WST as of Q4 2017.

  • BB&T Investment Services held 115 shares of West Pharmaceutical worth $12K as of Q4 2017.
  • BB&T Investment Services sold 4,209 West Pharmaceutical shares in Q4 2017, an estimated $413K.
  • West Pharmaceutical made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #932 holding.
  • BB&T Investment Services first reported a position in West Pharmaceutical in Q3 2017 and has held it in 2 quarters since.
  • BB&T Investment Services's West Pharmaceutical position peaked at $417K in Q3 2017.
  • 338 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.